Reports on the Nordic Life Science Markets

“To be able to control costs and serve patients, the world will need biosimilars,” says Róbert Wessman, Icelandic businessman and entrepreneur.

The new institute, AI Science Institute, brings together researchers, industry and technology developers to further strengthen knowledge development and practical application of artificial intelligence.

Antimicrobial resistance is one of the world’s most severe global health threats but there is still hope, including several Nordic innovative solutions.

The new incubator is designed to accelerate health and life science innovation in Finland.

The COVID-19 pandemic exposed global unpreparedness and made it very clear that investment in research efforts that address potential health crises is crucial. One such effort is the Nordic Health Crisis University Network, linking five Nordic universities with policymakers to enhance crisis management.

Umeå Biotech Incubator (UBI) has been awarded continued support from Kempestiftelserna for 2026.

Even though many have tried and few succeeded in the quest to find viable treatments for neurodegenerative diseases, Nordic drug developers continue to take different approaches to crack the riddle.